GlassScriptPhysician profile
Gordon J Ostrum
NPI 1033175005
$4,232.91
in general payments reported to CMS, 2019-2025
28 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,083 · 2020: $368 · 2021: $593 · 2022: $188.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Minerva Surgical, INC | $2,042.83 | 2019-2022 | |
| Boston Scientific Corporation | $465.17 | 2019 | |
| Amgen INC. | $339.82 | 2019-2021 | |
| Acessa Health INC. | $250.36 | 2019 | |
| Abbvie INC. | $204.07 | 2019-2021 | |
| Pfizer INC. | $94.35 | 2020-2021 | |
| Therapeuticsmd, INC. | $91.51 | 2019-2021 | |
| Agile Therapeutics, INC. | $88.97 | 2021 | |
| Renovia INC | $82.66 | 2020 | |
| Medtronic, INC. | $81.78 | 2021 | |
| Covidien LP | $58.51 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $42.22 | 2019-2020 | |
| Daiichi Sankyo INC. | $41.93 | 2020-2021 | |
| Astellas Pharma US INC | $39.76 | 2019 | |
| Exeltis, USA INC. | $37.09 | 2019-2021 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $34.42 | 2019 | |
| Evofem Biosciences, INC. | $33.63 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $30.99 | 2022 | |
| Amag Pharmaceuticals, INC. | $30.92 | 2019-2020 | |
| Pacira Pharmaceuticals Incorporated | $26.76 | 2020-2021 | |
| Coloplast Corp | $18.04 | 2019 | |
| Lupin INC. | $16.75 | 2020 | |
| Myovant Sciences INC. | $16.35 | 2021 | |
| Duchesnay USA Incorporated | $15.26 | 2019 | |
| Millicent US INC | $14.32 | 2019 | |
| Allergan, INC. | $12.13 | 2019 | |
| Hologic Sales and Service, LLC | $11.29 | 2021 | |
| Alydia Health | $11.02 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gordon Ostrum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.